相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nephrotoxicity and Efficacy Assessment of Polymyxin B Use in Renal Transplant Patients
Yu-Xin Wen et al.
INFECTION AND DRUG RESISTANCE (2022)
Population pharmacokinetics of polymyxin B in critically ill patients receiving continuous venovenous haemofiltration
Peile Wang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)
Risk Factors for Acute Kidney Injury Induced by Intravenous Polymyxin B in Chinese Patients with Severe Infection
Xuedong Jia et al.
INFECTION AND DRUG RESISTANCE (2022)
Population pharmacokinetics of polymyxin B: a systematic review
Na Chen et al.
ANNALS OF TRANSLATIONAL MEDICINE (2022)
Estimation of the area under concentration-time curve of polymyxin B based on limited sampling concentrations in Chinese patients with severe pneumonia
Wenqian Chen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjects
Xiaofen Liu et al.
JOURNAL OF INFECTION (2021)
A guide to therapeutic drug monitoring of β-lactam antibiotics
Andrew J. Fratoni et al.
PHARMACOTHERAPY (2021)
It's Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant Pseudomonas aeruginosa
Payam Behzadi et al.
ANTIBIOTICS-BASEL (2021)
Clinical outcomes and safety of polymyxin B in the treatment of carbapenem-resistant Gram-negative bacterial infections: a real-world multicenter study
Xiaojuan Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotic
Sebastian G. Wicha et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Rescuing the Last-Line Polymyxins: Achievements and Challenges
Sue C. Nang et al.
PHARMACOLOGICAL REVIEWS (2021)
External evaluation of published population pharmacokinetic models of polymyxin B
Ya-qian Li et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Development of ELISA formats for polymyxin B monitoring in serum of critically ill patients
Maksim A. Burkin et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2021)
Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey
Christian Lanckohr et al.
ANNALS OF INTENSIVE CARE (2021)
Comparing the Population Pharmacokinetics of and Acute Kidney Injury Due to Polymyxin B in Chinese Patients with or without Renal Insufficiency
Peile Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Therapeutic monitoring of vancomycin for serious -methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2020)
A Simple and Robust Liquid Chromatography With Tandem Mass Spectrometry Analytical Method for Therapeutic Drug Monitoring of Plasma and Cerebrospinal Fluid Polymyxin B1 and B2
Peile Wang et al.
THERAPEUTIC DRUG MONITORING (2020)
Therapeutic drug monitoring of polymyxin B by LC-MS/MS in plasma and urine
Xiaofen Liu et al.
BIOANALYSIS (2020)
Performance of Population Pharmacokinetic Models in Predicting Polymyxin B Exposures
Vincent H. Tam et al.
MICROORGANISMS (2020)
International Consensus Guidelines for the Optimal Use of the Polymyxins Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T. Tsuji et al.
PHARMACOTHERAPY (2019)
Quantification below the LLOQ in regulated LC-MS/MS assays: a review of bioanalytical considerations and cautions
Jeffrey X. Duggan
BIOANALYSIS (2019)
Analysis of the clinical antibacterial and antituberculosis pipeline
Ursula Theuretzbacher et al.
LANCET INFECTIOUS DISEASES (2019)
Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniaein mouse thigh and lung infection models
Cornelia B. Landersdorfer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Personalizing Polymyxin B Dosing Using an Adaptive Feedback Control Algorithm
Elizabeth A. Lakota et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Population Pharmacokinetics of Polymyxin B in Acutely III Adult Patients
Cristina Miglis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Population Pharmacokinetics of Polymyxin B
Pooja Manchandani et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives
Femke de Velde et al.
PHARMACOLOGICAL RESEARCH (2018)
Polymyxin B Pharmacokinetics in Adult Cystic Fibrosis Patients
Sean N. Avedissian et al.
PHARMACOTHERAPY (2018)
Safety and Security Regulations Against Biological Threats
Anna Bielecka-Oder
DEFENCE AGAINST BIOTERRORISM: METHODS FOR PREVENTION AND CONTROL (2018)
Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
Alexandre P. Zavascki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
The development and validation of a simple liquid chromatography-tandem mass spectrometry method for polymyxin B1 and B2 quantification in different matrices
Jenna Covelli et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
Development of a multi-matrix LC-MS/MS method for urea quantitation and its application in human respiratory disease studies
Jianshuang Wang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2017)
Factors Determining Nephrotoxicity and Mortality in Critical Care Patients Receiving Colistin
Ali Ciftci et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2017)
Biological Matrix Effects in Quantitative Tandem Mass Spectrometry-Based Analytical Methods: Advancing Biomonitoring
Parinya Panuwet et al.
CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY (2016)
Risk Factors for Colistin-Associated Acute Kidney Injury: A Multicenter Study from Turkey
Serdar Gul et al.
JAPANESE JOURNAL OF INFECTIOUS DISEASES (2016)
Simultaneous quantitation of polymyxin B1, polymyxin B2 and polymyxin B1-1 in human plasma and treated human urine using solid phase extraction and liquid chromatography-tandem mass spectrometry
Min Meng et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
A review on colistin nephrotoxicity
Atefeh Ordooei Javan et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Polymyxin B versus colistin: an update
Yiying Cai et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection
Soon-Ee Cheah et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Innovative approaches to optimizing the delivery of vancomycin in individual patients
Manjunath P. Pai et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy
Kady Phe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?
Gloria Wong et al.
BMC INFECTIOUS DISEASES (2014)
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Abiola O. Olaitan et al.
FRONTIERS IN MICROBIOLOGY (2014)
Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011)
Ronald N. Jones et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
Ana M. Sandri et al.
CLINICAL INFECTIOUS DISEASES (2013)
Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa
Djuli M. Hermes et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Ion suppression; A critical review on causes, evaluation, prevention and applications
Ambrose Furey et al.
TALANTA (2013)
The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Zakuan Z. Deris et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010)
Ana C. Gales et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Cross-Talk in Scheduled Multiple Reaction Monitoring Caused by In-Source Fragmentation in Herbicide Screening with Liquid Chromatography Electrospray Tandem Mass Spectrometry
Fenhong Song
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2011)
Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients
Jason A. Roberts et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models
Rajesh V. Dudhani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Attenuation of Colistin Bactericidal Activity by High Inoculum of Pseudomonas aeruginosa Characterized by a New Mechanism-Based Population Pharmacodynamic Model
Juergen B. Bulitta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models
Rajesh V. Dudhani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Calcineurin Inhibitor Nephrotoxicity
Maarten Naesens et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Microbiological assay for quantitative determination of polyoxin B
Li Sun et al.
PROCESS BIOCHEMISTRY (2009)
Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients
Alexandre P. Zavascki et al.
CLINICAL INFECTIOUS DISEASES (2008)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa
VH Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Bayesian analysis of population PK/PD models: General concepts and software
DJ Lunn et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2002)
In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis
J Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
分享论文
